Topical Liposomal Amphotericin B Gel Treatment for Cutaneous Leishmaniasis
Status:
Recruiting
Trial end date:
2022-01-01
Target enrollment:
Participant gender:
Summary
Comparison between placebo gel treatment to topical liposomal amphotericin B gel treatment
for cutaneous leishmaniasis of Leishmania species major and tropica.